Management of hirsutism in women of Mediterranean origin.
Explore the source record for details and available documents.
Bromocriptine↗
SEARCH · PubMed Health
Results for “Finasteride”
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
[Use of proscar in preoperative preparation of patients with benign prostatic hyperplasia before transureteral resection].
Effects of proskar-MSD used before transurethral resection (TUR) of the prostate in patients with benign prostatic hyperplasia (BPH) were studied with specification of the drug action on hematuria during and after operation. Patients with histologically verified BPH received proskar for 3 and 6 months in a dose of 5 mg/day. Control patients did not receive preoperative proskar. Of patients who received proskar for 3 months, TUR with estimation of the intraoperative blood loss and changes in microcirculation and structure of prostatic tissue induced by proskar was made in 20 patients (mean age 68 years). A 3-month course of proskar reduced prostatic volume and its hyperplasia by 18-20 cm3, on the average. Mean blood loss was about 111 ml vs control 223 ml. Dopplerography revealed consolidation of adenomatous tissue and decline of volumic blood flow in the prostate after 3-month proskar course. Thus, preoperative proskar administration before TUR of prostatic adenoma results in sclerosing of prostatic tissue, decrease of microcirculation manifesting intraoperatively with diminished hematuria and less number of subsequent complications; promotes a favourable outcome of the operation; improves life quality.
Combined Modality Therapy↗
[5-alpha reductase inhibitors or alpha blockers? The combination brakes best prostatic hyperplasia].
Explore the source record for details and available documents.
5-alpha Reductase Inhibitors↗
Dutasteride (Avodart) for benign prostatic hyperplasia.
Explore the source record for details and available documents.
Abnormalities, Drug-Induced↗
[Drugs against symptomatic, benign prostatic hyperplasia].
Explore the source record for details and available documents.
Adrenergic alpha-Antagonists↗
Second opinion. I have benign prostatic hyperplasia. The drug my doctor prescribed has helped somewhat, but I'm still making a lot of trips to the bathroom at night. Short of surgery, are there any new approaches to managing this condition that might be more helpful?
Explore the source record for details and available documents.
Adrenergic alpha-Antagonists↗
[Hormonal therapy for benign prostatic hyperplasia].
Explore the source record for details and available documents.
5-alpha Reductase Inhibitors↗
[New agents developed for the treatment of benign prostatic hyperplasia].
Explore the source record for details and available documents.
5-alpha Reductase Inhibitors↗
Benign prostatic hyperplasia.
Explore the source record for details and available documents.
Adrenergic alpha-Antagonists↗
[Dual 5-alpha reductase inhibitors in BPH (benign prostatic hyperplasia). Already after 1 month prostate shrinks].
Explore the source record for details and available documents.
5-alpha Reductase Inhibitors↗
By the way, doctor. I'm 77 and have an enlarged prostate. I take Proscar once a day and saw palmetto three times a day. Yet I still have to get up two to seven times a night to urinate. What can I do to reduce the frequency of urination?
Explore the source record for details and available documents.
Adrenergic alpha-Antagonists↗
[Prostatic adenoma: new drugs, new surgical techniques].
Explore the source record for details and available documents.
5-alpha Reductase Inhibitors↗
Pharmaceutical review.
Explore the source record for details and available documents.
Adrenergic alpha-Antagonists↗
Study of prostate cancer prevention drug shows potential and problems.
Explore the source record for details and available documents.
Enzyme Inhibitors↗
[Target enzyme].
Explore the source record for details and available documents.
5-alpha Reductase Inhibitors↗
[5-alpha reductase inhibitors plus alpha blockers. A combination therapy keeps a common disease checked].
Explore the source record for details and available documents.
5-alpha Reductase Inhibitors↗
[The tested combination is recommended. Are 5-alpha reductase inhibitors interchangeable?].
Explore the source record for details and available documents.
5-alpha Reductase Inhibitors↗
Mixed reviews for drug studied to prevent prostate cancer.
Explore the source record for details and available documents.
Enzyme Inhibitors↗